<DOC>
	<DOCNO>NCT01828762</DOCNO>
	<brief_summary>Although liver resection , liver transplantation , a-interferon , Transarterial Chemo Embolization ( TACE ) , percutaneous ethanol injection ( PEI ) , Percutaneous microwave coagulation therapy ( PMCT ) , Radiofrequency ablation ( RFA ) provide option treat patient HCC , high recurrence rate mid-late stage liver cancer still exist . The safety autologous Immune Cell Therapy Primary Hepatocellular Carcinoma ( HCC ) Patients Following Resection TACE Therapy evaluate .</brief_summary>
	<brief_title>Autologous Immune Cell Therapy Primary Hepatocellular Carcinoma Patients Following Resection TACE Therapy</brief_title>
	<detailed_description>The study single center , open label trial . To obtain safety information toxicity adverse event attributable subcutaneous injection autologous dendritic cell incubate irradiated autologous tumor stem cell suspend GM-CSF patient HCC .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Voluntary write informed consent sign patient legal guardian , obtain prior study enrollment . 2 . BCLC Classification AB 3 . Patients good surgical candidate HCC resection 4 . ECOG Performance Score , 01 5 . ChildPugh Rating , A 6 . Expected survival great 6 month 1 . History anaphylactic reaction GMCSF 2 . Congestive heart failure , unstable angina underlie cardiac disease ; history thrombosis currently require anticoagulation 3 . Mental psychological illness prevent cooperation treatment , efficacy evaluation , unable understand inform consent process 4 . Primary cancer kind location , hepatocellular carcinoma 5 . Excluding hepatitis , active unresolved infection include HIV , EBV , CMV , RPR , TB , etc . 6 . Autoimmune disease require therapy ; immunodeficiency , disease process require immunosuppressive therapy . 7 . Prior clinical trial require patient receive investigational drug within two week enrollment . 8 . Pregnant lactating woman . 9 . Patients intention receive transplantation 10 . Significant comorbidity active medical condition could eminently life threaten opinion investigator , include active blood clot bleed diathesis . 11 . Evidence metastatic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>DC</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>TC</keyword>
</DOC>